5 completed. 5 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 5 | Completed 5 |
Follow Rhinitis, Vasomotor: new trials by email Literature Review of Rhinitis, Vasomotor trials Research Report on Rhinitis, Vasomotor
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy/Safety of Pseudoephedrine Plus Levocetirizine Versus Placebo in Patients With Vasomotor Rhinitis Pseudoephedrine / Levocetirizine - Vasomotor Rhinitis | Phase 3 | Completed | Hanmi Pharmaceutical Company Limited | 137 | 2011-05-01 | 2013-05-23 |
| Consumer Preference Study of Two Formulations of Phenylephrine Hydrochloride (Study CL2008-15)(P07530)(COMPLETED) Phenylephrine Hydrochloride (HCl) Extended Release (ER) Tablets 30 mg, Phenylephrine Hydrochloride (HCl) Immediate Release (IR) tablets, 10 mg - Vasomotor Rhinitis, Seasonal Allergic Rhinitis | Phase 3 | Completed | Bayer | 331 | 2009-08-01 | 2015-03-11 |
| Study Of Adults And Adolescents With Vasomotor Rhinitis GW685698X - Rhinitis, Vasomotor | Phase 3 | Completed | GlaxoSmithKline | 352 | 2005-07-11 | 2018-03-13 |
| Once-Daily Investigational Nasal Spray In Adults And Adolescents With Vasomotor Rhinitis GW685698X - Vasomotor Rhinitis, Rhinitis, Vasomotor | Phase 3 | Completed | GlaxoSmithKline | 350 | 2005-07-01 | 2017-08-21 |
| Impact of Acupuncture on Vasomotor Rhinitis Acupuncture, Sham-laser acupuncture - Vasomotor Rhinitis, Acupuncture | Phase 3 | Completed | Ludwig-Maximilians - University of Munich | 24 | 1998-01-01 | 2015-01-13 |
Rhinitis, Allergic, Seasonal (1)
Nose Diseases (5) · Otorhinolaryngologic Diseases (5) · Respiratory Tract Diseases (5) · Rhinitis (5) · Hypersensitivity (1) · Hypersensitivity, Immediate (1) · Immune System Diseases (1) · Respiratory Hypersensitivity (1) · Rhinitis, Allergic (1)
Acupuncture Therapy (1) · Oxymetazoline (1) · Phenylephrine (1) · Pseudoephedrine (1) · Tablets (1) · levocetirizine (1)
GlaxoSmithKline (2) · Bayer (1) · Hanmi Pharmaceutical Company Limited (1) · Ludwig-Maximilians - University of Munich (1)
Germany (3) · Canada (2) · Czechia (2) · Norway (2) · Romania (2) · United States (2) · Puerto Rico (1) · South Korea (1)
Dominik Irnich, PD. Dr. (1) · Kyungmi Park, Ph.D. (1)